On Friday, Shares of American Capital Ltd. (NASDAQ:ACAS), gained 2.55% to $14.06.
Antares Capital and American Capital, declared that they were co-lead arrangers of a $170 million unitranche facility to support the acquisition of Kele, Inc. by Snow Phipps Group, LLC. Antares Capital acted as Agent. Kele is an independent distributor of peripheral control products used in building automation systems of commercial buildings in North America.
Douglas Cannaliato, Senior Managing Director at Antares Capital, said, “We’re thrilled to be lead arranger of this financing for Snow Phipps, ongoing our decade-long relationship with Kele. We have a lot of confidence in administration and a history of successful partnering with Snow Phipps.”
Ryan Brauns, Managing Director and Head of Sponsor Finance at American Capital, said, “We are delighted to have closed our second transaction with Snow Phipps in the last twelve months and were glad to partner with Antares to provide a joint execution.”
Founded in 1983 and headquartered in Memphis, TN, Kele supplies over 108,000 peripheral control products, counting pressure controls, sensors, and control valves, that are critical components for commercial and industrial buildings to operate efficiently. The products are used to detect and transmit information such as room temperature and humidity to building controllers, allowing building operators to manage internal environments, save on energy costs and keep expensive mechanical systems, such as large HVAC systems, running correctly.
American Capital, Ltd. is a private equity and venture capital firm. It is a business development company specializing in administration and employee buyouts, subordinated debt, leveraged finance, mezzanine, acquisition, recapitalization, middle market, early venture, mature, industry consolidation, and growth capital investments. The firm seeks to invest in senior debt mezzanine, unitranche, and equity financing for buyouts of private equity firms and direct in private and public companies. It also invests in special situations and in government.
Shares of Bristol-Myers Squibb Co (NYSE:BMY), declined -0.15% to $65.45, during its last trading session.
Bristol-Myers Squibb Company and Pfizer Inc., declared that 22 abstracts will be presented at the American Heart Association (AHA) Scientific Sessions 2015, to be held November 7-11 in Orlando, Florida. The new data, counting four oral presentations, contribute to the Bristol-Myers Squibb and Pfizer Alliance’s research in nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) in patients treated with Eliquis. Abstracts comprise new data analyses from the pivotal Phase 3 study, ARISTOTLE, as well as a number of real-world data analyses.
“The Alliance is looking forward to sharing new data from both clinical and real-world data analyses,” said Douglas Manion, M.D., head of specialty development, Bristol-Myers Squibb. “These data demonstrate the Alliance’s commitment to continue to evaluate Eliquis in different settings.”
“Clinical trial data are important in evaluating a medicine’s efficacy and safety under well-controlled circumstances,” said Rory O’Connor, M.D., senior vice president and head of Global Medical Affairs, Global Innovative Pharmaceuticals Business, Pfizer Inc. “These findings can be supplemented by real-world data, offering insight into the use of Eliquis for its approved indications in routine clinical practice.”
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
Finally, Shares of Commscope Holding Company Inc (NASDAQ:COMM), ended its last trade with -0.09% loss, and closed at $32.31.
CommScope Holding Company, plans to take part in a fireside chat at the Wells Fargo Technology, Media and Telecom Conference on Tuesday, November 10 at 10:45 a.m. ET.
CommScope Holding Company, Inc., together with its auxiliaries, provides connectivity and infrastructure solutions for wireless, business enterprise, and residential broadband networks worldwide. The company operates through three segments: Wireless, Enterprise, and Broadband.